Cellecta
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
320 Logue Ave, Mountain View, California...Phone Number
(650) 938-3910Website
www.cellecta.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
7
2
5
2
1
About Cellecta
Cellecta, Inc. specializes in genomic products and services aimed at drug target and biomarker discovery. Their offerings include a variety of CRISPR and RNAi libraries, along with services for functional screening, cell engineering, and bioinformatics analysis. They cater to clients seeking to identify and validate genes of interest for therapeutic applications, particularly in the fields of drug development and genomics. Cellecta empowers research with customizable options and extensive support for genomic analysis.Explore more
Cellecta Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cellecta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cellecta recently announced quarterly report
Check out if Cellecta is spiking on competitors!
Product Launch: Get notified when Cellecta launches new products
Funding: Get notified immidiatlly once Cellecta has new funding data
Cellecta, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Cellecta has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cellecta had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cellecta
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Cellecta
Compare insights from companies similar to Cellecta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cellecta is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cellecta is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cellecta.
Cellecta financials insights
Gather financial insights about Cellecta, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Cellecta Tech Stack
A closer look at the technologies used by Cellecta
Most Recent Scoops
Project
, according to a mid-level source in advertising & promotion, is planning to begin initiatives related to advocacy, loyalty, and referrals within three to six months.
Advertising, Relationship Marketing, Marketing Relationships
Project
, according to a mid-level source in advertising & promotion, is in the midst of initiatives related to video marketing.
Digital Marketing, Advertising, Video
Project
, according to a mid-level source in advertising & promotion, is in the midst of initiatives related to pay-per-click (PPC).
Digital Marketing, Advertising
Project
, according to a mid-level source in advertising & promotion, is in the midst of initiatives related to public relations. The organization is currently evaluating various vendors.
Advertising, Public Relations
Project
Advertising, Collaboration/Web Apps, Employee Relations
Cellecta News & Media
Cellecta, Inc. Launches Blood Microsampling Assay that Profiles 19,000 Human Protein-Coding Genes from One Drop of Dried Blood
The combination of convenient at-home, finger-prick blood collection and the ultra-sensitive DriverMapTM EXP Human Genome-Wide Profiling Kit greatly simplifies the discovery of clinically relevant transcriptome biomarkers. MOUNTAIN VIEW, Calif., May 6, 2025 /PRNewswire/ -- Cellecta, Inc....Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Controls to Ensure Consistent Quality and Optimal Performance of TCR and BCR Profiling Assays
The first-to-market DriverMap™ AIR RNA TCR/BCR spike-in calibration controls measure the accuracy, sensitivity, and linear range of sequencing-based immune repertoire profiling assays. MOUNTAIN VIEW, Calif., April 4, 2024 /PRNewswire/ -- Cellecta, Inc. today announced the launch of the...Cellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Mouse RNA TCR and BCR Kits for Sensitive Immune Repertoire Profiling
Comprehensive RNA Seq-based immune repertoire profiling technology extends its product line to include Mouse RNA sample profiling MOUNTAIN VIEW, Calif., Nov. 16, 2023 /PRNewswire/ -- Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) Mouse RNA TCR...Cellecta, Inc. Launches Genome-Wide CRISPR Chicken and Pig Knockout Libraries
CRISPR screening libraries for chicken and pig allow the study of gene disruptions in a single experiment to enable improved breeding and more MOUNTAIN VIEW, Calif., Oct. 9, 2023 /PRNewswire/ -- Cellecta, Inc. today announced the release of new pooled, single-module, CRISPR genome-wide...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cellecta
Sign Up For FreeTo access detailed company insights
Cellecta, Inc. specializes in genomic products and services aimed at drug target and biomarker discovery. Their offerings include a variety of CRISPR and RNAi libraries, along with services for functional screening, cell engineering, and bioinformatics analysis. They cater to clients seeking to identify and validate genes of interest for therapeuti... Read More
